Beneficial effects of music therapy on stress reduction

ISRCTN ISRCTN70947363
DOI https://doi.org/10.1186/ISRCTN70947363
Submission date
04/10/2020
Registration date
11/10/2020
Last edited
12/10/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Music therapy or sound interventions have been shown to benefit patients in terms of pain or fear relief and improvement of other patient-reported outcomes. The effect of stress on the heart, particularly the variation in heart rate, is known to indicate that more serious problems can occur later. The aim of this study is to investigate the effects of a sound intervention on heart rate.

Who can participate?
Patients who are exposed to increased stress levels due to their illness, as well as formally healthy people, can participate in the study.

What does the study involve?
The planned study project will investigate the effects of music therapy in patients and healthy individuals with an increased stress level, in particular with regard to a possible positive effect on the autonomic nervous system in terms of stress reduction. In order to take into account a possible positive effect of music intervention, a music intervention will therefore be compared to rest. Participants will have their heart rate measured before and after a 12-minute period of listening to music with either conventional headphones (CH; “MEZE 99 Classic”) or with the same – but internally modified – headphone (called “Lautsaenger”).

What are the possible benefits and risks of participating?
There are no known disadvantages for the participants in the study. There are no known harmful effects of music therapy. As music therapy is a recognised, established procedure whose effectiveness has already been proven in meta-analyses, the researchers hope to achieve a positive effect from which every participant in the study will benefit directly.

Where is the study run from?
University Medical Centre Mannheim (Germany)

When is the study starting and how long is it expected to run for?
May 2019 to September 2022

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Anna Hohneck
annalena.hohneck@umm.de

Contact information

Dr Anna Hohneck
Scientific

First Department of Medicine – Cardiology
University Medical Center Mannheim, Heidelberg University
Theodor-Kutzer-Ufer 1-3
Mannheim
68167
Germany

ORCiD logoORCID ID 0000-0002-7629-2770
Phone +49 (0)17670738117
Email annalena.hohneck@umm.de

Study information

Study designInterventional randomized parallel trial
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Hospital, University/medical school/dental school
Study typeQuality of life
Participant information sheet ISRCTN70947363_PIS_v1.1_30Sept2019.pdf
Scientific titleBeneficial effects of a sound intervention in the form of music therapy on stress reduction
Study hypothesisMusic therapy is a recognised medical procedure that uses music to address physical, emotional, cognitive and social disorders. The interventions used include playing instruments, vocal and instrumental improvisation, singing, composition/songwriting, music guided imagination techniques and listening to music.
Music therapy is said to have a positive effect on well-being, stress management, pain relief, emotional expression, memory, communication skills and physical rehabilitation.
There is some evidence that music therapy can be a useful supportive measure in the treatment of chronically ill patients. Results of recent systematic reviews suggest that music interventions have moderate to strong treatment effects on the parameters of anxiety, depression, fatigue, pain and quality of life in chronically ill patients. In addition, a slight improvement in vital parameters such as heart rate, blood pressure and respiratory rate has been described, which indicate a reduction in stress. This study will therefore examine the effects of music therapy in patients exposed to higher stress levels, especially with regard to a possible positive effect on the autonomic nervous system in terms of stress reduction.
Ethics approval(s)Approved 08/11/2019, Local ethical committee, Medical Ethics Commission II, Faculty of Medicine Mannheim (University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany; +49 (0)621 383 71770; ethikkommission-II@medma-uni-heidelberg.de), ref: 2019-736N
ConditionIncreased stress level
InterventionCurrent interventions as of 15/05/2023:

Participants are randomized to a 12-minute sound intervention (classical music) with either conventional headphones (CH; “MEZE 99 Classic”) or with the same – but internally modified – headphone (called “Lautsaenger”).

_____

Previous interventions:

All participants receive both a 15-minute sound intervention and a 15-minute rest intervention on separate days as part of a cross-over design.

The order of interventions is randomly decided using sealed envelopes.

The sound intervention was performed with an instrument called "Heaven and Earth" (http://klangkoerper.de/himmel-und-erde.html). This instrument consists of a semi-open resonance body with 29 strings (24 of those in C1sharp, two in C2sharp, two C3sharp, and one in G3sharp). The monochord is placed on the chest during the intervention to ensure optimal transmission of the vibrations.

The rest intervention is done in a lying position for 15 minutes after the 10-minute resting phase.

The gap between the two intervention days is a maximum of 4 weeks.
Intervention typeOther
Primary outcome measureCardiovascular parameters (heart rate, blood pressure, heart rate variability and pulse wave velocity) assessed non-invasively using the VascAssist 2 device at baseline and after the rest and sound interventions
Secondary outcome measuresCurrent secondary outcome measures as of 15/05/2023:

1. Numeric rating scale (NRS) for emotions and stress before and after sound intervention (emotional well-being, pain, anger, anxiety, sadness, stress, music for coping stress).
2. The modified Maslach Burnout Inventory (MBI) to assess the burnout risk before and after sound intervention.
3. NRS for subjective sound perception and to what extent listening stimulated the imagination was fulfilled after sound intervention. In addition, dichotomous questions were used to evaluate the headphone systems in particular.

_____

Previous secondary outcome measures:

Quality of life assessed using the health-related quality of life (HRQOL) questionnaire at baseline and after the rest and sound interventions
Overall study start date01/05/2019
Overall study end date01/09/2022

Eligibility

Participant type(s)Healthy volunteer, Mixed
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants100
Total final enrolment100
Participant inclusion criteria1. Age ≥18 years
2. Written informed consent
Participant exclusion criteria1. Acute myocardial infarction or stroke (within the past 30 days)
2. Cardiogenic shock
3. Indication for an aortocoronary bypass operation
4. Known minimal heart rate at rest below 50 bpm
5. Need for pacemaker stimulation
6. Hypotension with systolic blood pressure <80 mmHg or uncontrolled hypertension with systolic blood pressure ≥180 mmHg, bilateral axilla dissection
7. Parkinson’s disease or tremor of other origin
8. Atrial fibrillation
Recruitment start date01/07/2020
Recruitment end date01/09/2020

Locations

Countries of recruitment

  • Germany

Study participating centre

Heidelberg University
Third Department of Medicine (Hematology and Oncology)
Interdisciplinary Tumor Center Mannheim (ITM)
Medical Faculty Mannheim
Theodor-Kutzer-Ufer 1-3
Mannheim
68167
Germany

Sponsor information

University Medical Centre Mannheim
University/education

Theodor-Kutzer-Ufer 1-3
Mannheim
68167
Germany

Phone +49 6213832204
Email med1@umm.de
Website https://www.umm.de/i-medizinische-klinik/forschung-lehre/studienzentrum/
ROR logo "ROR" https://ror.org/05sxbyd35

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date01/04/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal (Integrative Cancer Therapies)
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from the corresponding author Dr Anna Hohneck (annalenahohneck@umm.de). The data will be provided as anonymized data (Excel file), upon request from scientific stuff (after verification). The data transfer will take place via secure transfer services to guarantee security. The transmission of raw data will only take place after prior consultation with the participants and their corresponding consent. The data is provided only for transparency purposes only and not for further analysis.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version v1.1 30/09/2019 05/11/2020 No Yes
Protocol file 05/11/2020 No No
Results article 01/01/2021 13/08/2021 Yes No
Results article 11/10/2023 12/10/2023 Yes No

Additional files

ISRCTN70947363_PIS_v1.1_30Sept2019.pdf
uploaded 05/11/2020
ISRCTN70947363_PROTOCOL.pdf
uploaded 05/11/2020

Editorial Notes

12/10/2023: Publication reference added.
15/05/2023: The following changes were made to the trial record:
1. The study design was changed from "Interventional randomized crossover trial" to "Interventional randomized parallel trial".
2. The study setting University/medical school/dental school was added.
3. The overall end date was changed from 01/08/2020 to 01/09/2022.
4. The interventions were changed.
5. The secondary outcome measures were changed.
6. The participant type Healthy volunteer was added.
7. The target number of participants was changed from 150 to 100.
8. The total final enrolment was changed from 52 to 100.
9. The recruitment start date was changed from 08/11/2019 to 01/07/2020.
10. The recruitment end date was changed from 24/04/2020 to 01/09/2020.
11. The intention to publish date was changed from 01/11/2020 to 01/04/2023.
12. The plain English summary was updated to reflect these changes.
13/08/2021: Internal review.
06/04/2021: Publication reference added.
05/11/2020: Uploaded protocol (not peer reviewed). Uploaded participant information sheet.
06/10/2020: Trial's existence confirmed by Medical Ethics Commission II, Faculty of Medicine Mannheim.